357 related articles for article (PubMed ID: 16192737)
1. Adrenal pathophysiology: lessons from the Carney complex.
Groussin L; Cazabat L; René-Corail F; Jullian E; Bertherat J
Horm Res; 2005; 64(3):132-9. PubMed ID: 16192737
[TBL] [Abstract][Full Text] [Related]
2. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
Cazabat L; Ragazzon B; Groussin L; Bertherat J
Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
[TBL] [Abstract][Full Text] [Related]
3. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
[TBL] [Abstract][Full Text] [Related]
4. Carney complex (CNC).
Bertherat J
Orphanet J Rare Dis; 2006 Jun; 1():21. PubMed ID: 16756677
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex).
Stratakis CA
Ann N Y Acad Sci; 2002 Jun; 968():3-21. PubMed ID: 12119264
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase A alterations in endocrine tumors.
Yu B; Ragazzon B; Rizk-Rabin M; Bertherat J
Horm Metab Res; 2012 Sep; 44(10):741-8. PubMed ID: 22752956
[TBL] [Abstract][Full Text] [Related]
7. Carney complex.
Espiard S; Bertherat J
Front Horm Res; 2013; 41():50-62. PubMed ID: 23652670
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular genetics of primary pigmented nodular adrenocortical disease.
Sandrini F; Stratakis C
Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):637-41. PubMed ID: 15761532
[TBL] [Abstract][Full Text] [Related]
9. A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds.
Groussin L; Horvath A; Jullian E; Boikos S; Rene-Corail F; Lefebvre H; Cephise-Velayoudom FL; Vantyghem MC; Chanson P; Conte-Devolx B; Lucas M; Gentil A; Malchoff CD; Tissier F; Carney JA; Bertagna X; Stratakis CA; Bertherat J
J Clin Endocrinol Metab; 2006 May; 91(5):1943-9. PubMed ID: 16464939
[TBL] [Abstract][Full Text] [Related]
10. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.
Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos SG; Robinson-White A; Lenherr SM; Weinberg FD; Claflin ES; Batista D; Bourdeau I; Voutetakis A; Sandrini F; Meoli EM; Bauer AJ; Cho-Chung YS; Bornstein SR; Carney JA; Stratakis CA
J Med Genet; 2004 Dec; 41(12):923-31. PubMed ID: 15591278
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase A and its role in human neoplasia: the Carney complex paradigm.
Bossis I; Voutetakis A; Bei T; Sandrini F; Griffin KJ; Stratakis CA
Endocr Relat Cancer; 2004 Jun; 11(2):265-80. PubMed ID: 15163302
[TBL] [Abstract][Full Text] [Related]
12. [Carney complex].
Losada Grande EJ; Al Kassam Martínez D; González Boillos M
Endocrinol Nutr; 2011; 58(6):308-14. PubMed ID: 21536508
[TBL] [Abstract][Full Text] [Related]
13. Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency.
Mavrakis M; Lippincott-Schwartz J; Stratakis CA; Bossis I
Hum Mol Genet; 2006 Oct; 15(19):2962-71. PubMed ID: 16963469
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.
Kirschner LS; Carney JA; Pack SD; Taymans SE; Giatzakis C; Cho YS; Cho-Chung YS; Stratakis CA
Nat Genet; 2000 Sep; 26(1):89-92. PubMed ID: 10973256
[TBL] [Abstract][Full Text] [Related]
15. Bilateral adrenal Cushing's syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease.
Lacroix A; Bourdeau I
Endocrinol Metab Clin North Am; 2005 Jun; 34(2):441-58, x. PubMed ID: 15850852
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning, chromosomal localization of human peripheral-type benzodiazepine receptor and PKA regulatory subunit type 1A (PRKAR1A)-associated protein PAP7, and studies in PRKAR1A mutant cells and tissues.
Liu J; Matyakhina L; Han Z; Sandrini F; Bei T; Stratakis CA; Papadopoulos V
FASEB J; 2003 Jun; 17(9):1189-91. PubMed ID: 12692076
[TBL] [Abstract][Full Text] [Related]
17. Primary pigmented nodular adrenocortical disease and Cushing's syndrome.
Horvath A; Stratakis C
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1238-44. PubMed ID: 18209861
[TBL] [Abstract][Full Text] [Related]
18. Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families.
Pereira AM; Hes FJ; Horvath A; Woortman S; Greene E; Bimpaki E; Alatsatianos A; Boikos S; Smit JW; Romijn JA; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2010 Jan; 95(1):338-42. PubMed ID: 19915019
[TBL] [Abstract][Full Text] [Related]
19. Familial isolated primary pigmented nodular adrenocortical disease associated with a novel low penetrance PRKAR1A gene splice site mutation.
Storr HL; Metherell LA; Dias R; Savage MO; Rasmussen AK; Clark AJ; Main KM
Horm Res Paediatr; 2010; 73(2):115-9. PubMed ID: 20190548
[TBL] [Abstract][Full Text] [Related]
20. Human tumors associated with Carney complex and germline PRKAR1A mutations: a protein kinase A disease!
Stergiopoulos SG; Stratakis CA
FEBS Lett; 2003 Jul; 546(1):59-64. PubMed ID: 12829237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]